Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Rituximab in the Treatment of Graves' Disease
This study has been completed.
Study NCT00150111 Information provided by Odense University Hospital
First Received: September 6, 2005 Last Updated: October 5, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graves´ Disease
Thyroid Associated Ophthalmopathy
Additional conditions recognized in this trial
Graves Disease
Graves Ophthalmopathy
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Exophthalmos
Eye Diseases
Eye Diseases, Hereditary
Goiter
Hyperthyroidism
Immune System Diseases
Orbital Diseases
Thyroid Diseases
Interventions listed in this trial
Methimazole
Rituximab
Immunization with various vaccines
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Antithyroid Agents
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Odense University Hospital
Back to top of Main Content
